Search

Amolkumar S Karwa

from Saint Louis, MO
Age ~43
Get Report
Also known as:
R Karwa
Phone and address:
2224 Divot Dr, Saint Louis, MO 63131
Related to:
Sheetal Karwa
Connected to:
Shweta Karwa, 33Elizabeth M Karwacki, 34Marion E Karwacki, 83Donna M Karwal, 88George E Karwal, 66Leonard D Karwan, 77Ariel R Karwat, 32Edyta I Karwat, 52Niyati M Karwat, 37Deborah A Karwath, 67

Amolkumar Karwa Phones & Addresses

  • 2224 Divot Dr, Saint Louis, MO 63131
  • Saint Charles, MO
  • Philadelphia, PA
  • Paoli, PA

Work

Company: Covidien Dec 2007 Position: Biologist ii

Education

Degree: MS School / High School: Drexel University 2003 to 2005

Skills

Recombinant protein expression systems a... • DNA and plasmid extraction • and Cloning techniques • RT-PCR techniques • SDS Gel electrophoresis • Western Blots • Protein Lyophilization techniques • Mammalian cell culture • in vitro toxicity assays • cell based assays • protein assays • Animal (mice) handling and Surgery • Immunohistochemistry • tissue staining and fluorescent imaging • Hands-on experience with Epifluorescence... • Confocal Microscopy • and related optics

Awards

Awarded Dean's Fellowship (2003-04), Dre...

Interests

Rapid Disease Diagnostic tools, Nanotech...

Industries

Biotechnology

Resumes

Resumes

Amolkumar Karwa Photo 1

Amolkumar Karwa

View page
Position:
Biologist II at Covidien
Location:
Greater St. Louis Area
Industry:
Biotechnology
Work:
Covidien since Dec 2007
Biologist II
LifeSensors Mar 2006 - Nov 2007
Research Scientist
Drexel University Apr 2004 - Dec 2005
Graduate Research Assistant
NATIONAL CHEMICAL LABORATORIES, INC. 2001 - 2002
Trainee
Education:
Drexel University 2003 - 2005
MS
Skills:
Recombinant protein expression systems and protein purification
DNA and plasmid extraction
and Cloning techniques
RT-PCR techniques
SDS Gel electrophoresis
Western Blots
Protein Lyophilization techniques
Mammalian cell culture
in vitro toxicity assays
cell based assays
protein assays
Animal (mice) handling and Surgery
Immunohistochemistry
tissue staining and fluorescent imaging
Hands-on experience with Epifluorescence Microscopy
Confocal Microscopy
and related optics
Interests:
Rapid Disease Diagnostic tools, Nanotechnology and its application for diagnostics, noninvasive medical device development, benchside to bedside product development, Quality Assurance using Six Sigma tools, project management
Honor & Awards:
Awarded Dean's Fellowship (2003-04), Drexel University, , Awarded National Merit Scholarship (1998-2002) by the Government of India for undergraduate studies.

Publications

Us Patents

Methods And Compositions For Enhanced Protein Expression And Purification

View page
US Patent:
20120065106, Mar 15, 2012
Filed:
Dec 28, 2007
Appl. No.:
12/521468
Inventors:
Tauseef R. Butt - Malvern PA, US
Tadas Panavas - Wayne PA, US
Amolkumar Karwa - Paoli PA, US
Raymond J. Peroutka - Philadelphia PA, US
Jeffrey G. Marblestone - Philadelphia PA, US
Assignee:
LIFESENSORS, INC. - Malvern PA
International Classification:
C40B 40/10
C07K 14/00
C12N 15/63
C12P 21/02
C12N 5/10
C12N 1/19
C12N 1/21
C07H 21/00
C12N 9/50
US Classification:
506 18, 536 231, 536 235, 536 236, 536 2374, 530350, 4353201, 435219, 536 232, 435375, 4352542, 43525233, 435348, 435 697
Abstract:
Methods for enhancing expression levels, secretion, and purification of heterologous fusion proteins in a host cell are disclosed.

Methods Of Quantitatively Assessing Inflammation With Biosensing Nanoparticles

View page
US Patent:
20100130367, May 27, 2010
Filed:
Jul 11, 2007
Appl. No.:
12/307901
Inventors:
Sreekant Murthy - Sewell NJ, US
Elisabeth S. Papazoglou - Yardley PA, US
Kambiz Pourrezaei - Gladwyne PA, US
Som Tyagi - Boothwyn PA, US
Amolkumar Karwa - Paoli PA, US
Assignee:
Drexel University - Philadelphia PA
International Classification:
C40B 30/00
G01N 33/573
G01N 33/536
G01N 33/53
C12Q 1/68
US Classification:
506 7, 435 71, 435 74, 435 72, 435 792, 435 6
Abstract:
The present invention includes a method of using one or more biomarkers to identify individuals with inflammatory disease using Quantum Dots conjugated to targeting moieties that will specifically bind to biomarker proteins or nucleic acids encoding the biomarker, where detection of the biomarker is associated with the inflammatory disease.

Compounds And Compositions For Use In Phototherapy And In Treatment Of Ocular Neovascular Disease And Cancers

View page
US Patent:
20140370005, Dec 18, 2014
Filed:
Jun 26, 2014
Appl. No.:
14/316415
Inventors:
- Hazelwood MO, US
Raghavan Rajagopalan - Hazelwood MO, US
David W. Berberich - Hazelwood MO, US
Amolkumar Karwa - Hazelwood MO, US
Richard B. Dorshow - Hazelwood MO, US
International Classification:
C07D 489/02
C07D 221/28
A61K 45/06
A61K 31/485
US Classification:
4241331, 424649, 514 34, 514 49, 514 50, 514274, 514282, 514289
Abstract:
The invention relates generally to anti-angiogenesis agents and related methods of using to anti-angiogenesis agents for biomedical applications including direct monotherapy and combination therapy for treatment of an angiogenesis related condition. In an embodiment, the invention provides a class of opioid compounds and structurally related opioid derivatives exhibiting anti-VEGF activity for use in therapeutic procedures, including phototherapy. Opioid compounds and structurally related opioid derivatives of the invention may be administered alone or in combination with administration of a phototherapy agent and/or other therapeutic agent.

Compounds And Compositions For Use In Phototherapy And In Treatment Of Ocular Neovascular Disease And Cancers

View page
US Patent:
20140370006, Dec 18, 2014
Filed:
Jun 26, 2014
Appl. No.:
14/316443
Inventors:
- Hazelwood MO, US
Raghavan Rajagopalan - Hazelwood MO, US
David W. Berberich - Hazelwood MO, US
Amolkumar Karwa - Hazelwood MO, US
Richard B. Dorshow - Hazelwood MO, US
International Classification:
C07D 489/02
C07D 221/28
A61K 45/06
A61K 31/485
US Classification:
4241331, 424649, 514 34, 514 49, 514 50, 514274, 514282, 514289
Abstract:
The invention relates generally to anti-angiogenesis agents and related methods of using to anti-angiogenesis agents for biomedical applications including direct monotherapy and combination therapy for treatment of an angiogenesis related condition. In an embodiment, the invention provides a class of opioid compounds and structurally related opioid derivatives exhibiting anti-VEGF activity for use in therapeutic procedures, including phototherapy. Opioid compounds and structurally related opioid derivatives of the invention may be administered alone or in combination with administration of a phototherapy agent and/or other therapeutic agent.
Control profile
Amolkumar S Karwa from Saint Louis, MO, age ~43 Get Report